标题
HIV nucleoside reverse transcriptase inhibitors
作者
关键词
-
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 240, Issue -, Pages 114554
出版商
Elsevier BV
发表日期
2022-06-21
DOI
10.1016/j.ejmech.2022.114554
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
- (2022) Tanuja Narayansamy Gengiah et al. BMJ Open
- Avoiding Drug Resistance in HIV Reverse Transcriptase
- (2021) Maria E. Cilento et al. CHEMICAL REVIEWS
- Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
- (2021) Dharma Rao Tompa et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Tenofovir Alafenamide (TAF) for HIV Prevention: Review of the Proceedings from the Gates Foundation Long Acting (LA) TAF Product Development Meeting
- (2021) Joseph W. Romano et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial
- (2021) Jean-Michel Molina et al. Lancet HIV
- Development of Human Immunodeficiency Virus Type 1 Resistance to 4’-Ethynyl-2-Fluoro-2’-Deoxyadenosine (EFdA) Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor Resistant-Strains
- (2021) Maria E. Cilento et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
- (2021) Randolph P. Matthews et al. NATURE MEDICINE
- Entecavir-loaded poly (lactic-co-glycolic acid) microspheres for long-term therapy of chronic hepatitis-B: Preparation and in vitro and in vivo evaluation
- (2019) Chunyan Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Fifty Years in Search of Selective Antiviral Drugs
- (2019) Erik De Clercq JOURNAL OF MEDICINAL CHEMISTRY
- Exploration of long-acting implant formulations of hepatitis B drug entecavir
- (2019) Steven J. Henry et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
- (2019) Ibrahim M Ibrahim et al. International Journal of Nanomedicine
- Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1
- (2019) F. Xavier Ruiz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): Our past twenty years
- (2019) Chunlin Zhuang et al. Acta Pharmaceutica Sinica B
- Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H
- (2019) Lei Wang et al. ACCOUNTS OF CHEMICAL RESEARCH
- A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
- (2019) Jonathan T. Su et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
- (2018) Martin Markowitz et al. Current Opinion in HIV and AIDS
- Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial
- (2018) Chloe Orkin et al. Lancet HIV
- Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission
- (2018) Subhra Mandal et al. JOURNAL OF CONTROLLED RELEASE
- The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
- (2018) Vigneshwaran Namasivayam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment
- (2017) A. S. Lok et al. JOURNAL OF VIRAL HEPATITIS
- An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection
- (2016) Subhra Mandal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Factors associated with HBV virological breakthrough
- (2016) Suzanne Sheppard-Law et al. ANTIVIRAL THERAPY
- Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)
- (2016) Zhe Li Salie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors
- (2015) Gabriel Birkus et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of HIV-1 Resistance to Tenofovir AlafenamideIn Vitro
- (2015) Nicolas A. Margot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate
- (2015) Christian Callebaut et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial
- (2015) Christophe Vanpouille et al. CLINICAL INFECTIOUS DISEASES
- An injectable liquid crystal system for sustained delivery of entecavir
- (2015) Jong-Lae Lim et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
- (2014) Paul E. Sax et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
- (2014) M. Markowitz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
- (2014) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Characterization of a Novel HIV-1 Nucleotide-Competing Reverse Transcriptase Inhibitor Series
- (2013) D. Rajotte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Substitutions at the 4′ and 2 Positions on the Bioactivity of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine
- (2013) Karen A. Kirby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Combinations of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine with Clinically Used Antiretroviral Drugs
- (2013) Atsuko Hachiya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nucleotide competing reverse transcriptase inhibitors: Discovery of a series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
- (2013) Clint A. James et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors
- (2013) Martin Tremblay et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: In vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
- (2013) Claudio F. Sturino et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer
- (2013) Maryam Ehteshami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA
- (2013) Eleftherios Michailidis et al. Retrovirology
- Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability
- (2013) Iris Usach et al. Journal of the International AIDS Society
- Exploiting the Anti-HIV-1 Activity of Acyclovir: Suppression of Primary and Drug-Resistant HIV Isolates and Potentiation of the Activity by Ribavirin
- (2012) Christophe Vanpouille et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In silico study supports the efficacy of a reduced dose regimen for stavudine
- (2011) Selwyn J. Hurwitz et al. ANTIVIRAL RESEARCH
- HIV-1 RT-Associated RNase H Function Inhibitors: Recent Advances in Drug Development
- (2010) E. Tramontano et al. CURRENT MEDICINAL CHEMISTRY
- Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection
- (2010) P. L. Anderson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structural basis of HIV-1 resistance to AZT by excision
- (2010) Xiongying Tu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate
- (2010) Giovanni Maga et al. Viruses-Basel
- Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
- (2009) Tomas Cihlar et al. ANTIVIRAL RESEARCH
- Lamivudine for the treatment of HIV
- (2009) Princy N Kumar et al. Expert Opinion on Drug Metabolism & Toxicology
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
- (2009) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human Tissues
- (2008) Andrea Lisco et al. Cell Host & Microbe
- Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
- (2008) Martin S. Hirsch et al. CLINICAL INFECTIOUS DISEASES
- A Review of the Pharmacokinetics of Abacavir
- (2008) Geoffrey J Yuen et al. CLINICAL PHARMACOKINETICS
- 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants
- (2008) Atsushi Kawamoto et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”
- (2008) Maryam Ehteshami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase
- (2008) Egor P. Tchesnokov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
- (2008) Stefan G. Sarafianos et al. JOURNAL OF MOLECULAR BIOLOGY
- Unknown
- (2008) G. Birkus et al. MOLECULAR PHARMACOLOGY
- Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors
- (2008) Nicolas Sluis-Cremer et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now